← FDA Drug Approvals (Drugs@FDA)

NOVOLIN 70/30

BLA · Biologics License Application · Sponsor: NOVO NORDISK INC · Approved 1991-06-25

Drug application

FDA Application #
BLA019991
Application type
Biologics License Application
Brand name
NOVOLIN 70/30
Generic name
HUMAN INSULIN
Active ingredients
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Over-the-counter
Sponsor
NOVO NORDISK INC
Manufacturer
Novo Nordisk
First approval
1991-06-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown